"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 6 | 1 | 7 |
| 1996 | 6 | 6 | 12 |
| 1997 | 5 | 5 | 10 |
| 1998 | 5 | 2 | 7 |
| 1999 | 4 | 4 | 8 |
| 2000 | 3 | 3 | 6 |
| 2001 | 3 | 4 | 7 |
| 2002 | 2 | 1 | 3 |
| 2003 | 9 | 4 | 13 |
| 2004 | 5 | 5 | 10 |
| 2005 | 1 | 7 | 8 |
| 2006 | 7 | 4 | 11 |
| 2007 | 5 | 4 | 9 |
| 2008 | 7 | 10 | 17 |
| 2009 | 6 | 6 | 12 |
| 2010 | 3 | 5 | 8 |
| 2011 | 6 | 3 | 9 |
| 2012 | 4 | 4 | 8 |
| 2013 | 4 | 4 | 8 |
| 2014 | 1 | 3 | 4 |
| 2015 | 4 | 5 | 9 |
| 2016 | 2 | 1 | 3 |
| 2017 | 4 | 6 | 10 |
| 2018 | 5 | 4 | 9 |
| 2019 | 5 | 9 | 14 |
| 2020 | 2 | 2 | 4 |
| 2021 | 2 | 8 | 10 |
| 2022 | 1 | 6 | 7 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Reply to: Anti-CD4+ autoantibodies in immunological non-responder people with HIV: cause of CD4+ T-cell depletion? AIDS. 2023 Mar 01; 37(3):553-554.
-
COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity. J Med Virol. 2023 01; 95(1):e28134.
-
COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman. J Autoimmun. 2022 10; 132:102896.
-
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
-
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals. Front Immunol. 2022; 13:866181.
-
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis. 2022 08; 81(8):1143-1150.
-
Preclinical stage abundance and nuclear antigen reactivity of faecal Immunoglobulin A vary among males and females of lupus-prone mouse models. Immunology. 2022 04; 165(4):497-507.
-
Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 03; 74(3):496-507.
-
Pro-inflammatory IgG1 N-glycan signature correlates with primary graft dysfunction onset in COPD patients. Transpl Immunol. 2022 04; 71:101491.
-
Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages. Ann Rheum Dis. 2022 02; 81(2):255-267.